A detailed history of Hall Laurie J Trustee transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hall Laurie J Trustee holds 4,760 shares of VRTX stock, worth $2.14 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
4,760
Previous 4,605 3.37%
Holding current value
$2.14 Million
Previous $2.16 Million 2.55%
% of portfolio
0.7%
Previous 0.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$460.0 - $505.78 $71,300 - $78,395
155 Added 3.37%
4,760 $2.21 Million
Q2 2024

Jul 22, 2024

BUY
$392.81 - $485.53 $7,856 - $9,710
20 Added 0.44%
4,605 $2.16 Million
Q1 2024

Apr 23, 2024

BUY
$407.69 - $446.08 $1.75 Million - $1.91 Million
4,285 Added 1428.33%
4,585 $1.92 Million
Q1 2021

Apr 15, 2021

BUY
$207.02 - $241.31 $62,106 - $72,393
300 New
300 $64,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hall Laurie J Trustee Portfolio

Follow Hall Laurie J Trustee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

News

Stay updated on Hall Laurie J Trustee with notifications on news.